Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BL-15
- Development stage
- Preclinical
- Lead developer
- BioLeonhardt
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Implant
01
Overview
BL-15 is a proprietary 15-component regenerative composition developed by BioLeonhardt for heart regeneration. It is designed to be delivered via a micro-infusion pump as part of a multi-modal platform that combines bioelectric stimulation with biological factors. The composition is intended to promote stem cell homing, angiogenesis, and myocardial repair in patients with heart failure and other cardiovascular conditions. The cocktail typically includes a mixture of growth factors, proteins, and signaling molecules such as SDF-1, VEGF, HGF, and IGF-1, which work synergistically to recruit endogenous stem cells and support the regeneration of damaged heart tissue.
- Other names
- BL-15 CompositionBL15 CompositionBL 15 CompositionBioLeonhardt 15BioLeonhardt15BioLeonhardt-15
02
Targets
CXCR4 (C-X-C motif chemokine receptor 4)CXCR7 (CXC chemokine receptor 7)FGFR (Fibroblast growth factor receptor)CSF3R (Granulocyte colony-stimulating factor receptor)IGF-1R (Insulin-like growth factor 1 receptor)PDGFR (PDGFR family)VEGFR2 (Vascular endothelial growth factor receptor 2)MET (Mesenchymal-epithelial transition factor receptor)NOS3 (eNOS)FGF (Fibroblast growth factor 6)FST (Follistatin)G-CSF (Granulocyte colony-stimulating factor)HGF (Hepatocyte growth factor)IGF-1 (Insulin-like growth factor 1)CXCL12 (C-X-C motif chemokine ligand 12)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on BL-15.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BL-15.